Batulicin Nusantara Maritim Tbk vs Merck Tbk. — how do they compare? Batulicin Nusantara Maritim Tbk trades at Rp930 (market cap 3.22T, 11.6K 24h volume), while Merck Tbk. trades at Rp3,740 (market cap 1.68T, 22.8K 24h volume). The key difference: Batulicin Nusantara Maritim Tbk is the larger of the two by market cap, and Merck Tbk. is more actively traded (22.8K versus 11.6K). Which is the better fit depends on your goals.
| BESS | MERK | |
|---|---|---|
Market Cap | 3.22T | 1.68T |
Volume | 11.6K | 22.8K |
Lot | 116 | 228 |
Turnover | 10.49M | 82.9M |
Average Price | 904.18 | 3,636.14 |
Value | 10.49M | 82.9M |
Indicative Equilibrium Price | — | 3,520 |
Indicative Equilibrium Volume | — | 60 |
Trailing returns across standard periods
Latest headlines on both assets
PT Batulicin Nusantara Maritim Tbk (the “Company”) was established based on Notarial Deed No. 53 dated May 25, 2011 of Muhammad Faried Zain, S.H., M.H., notary in Banjarmasin. The Company’s immediate Parent Company is PT Batulicin Enam Sembilan Transportasi, and its Ultimate Parent Company is PT Batulicin Enam Sembilan. The Company started its commercial operations in 2012.
Read more on BESS →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →